ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: SA-PO300

Controls but Not Patients with Calcium Nephrolithiasis Secrete Less Urinary Uromodulin After Salt Loading

Session Information

Category: Bone and Mineral Metabolism

  • 502 Bone and Mineral Metabolism: Clinical

Authors

  • Bani Hani, Salar, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Wolf, Matthias Tilmann, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Sakhaee, Khashayar, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
Background

Calcium is the most common constituent of kidney stones. Uromodulin (UMOD) enhances TRPV5 membrane abundance increasing renal Ca2+ absorption thus reducing hypercalciuria. UMOD stimulates Na+absorption via NKCC2 causing hypertension. High salt intake is also risk factor for nephrolithiasis. We hypothesize that a higher urinary UMOD secretion with a high salt diet compensates for the higher stone risk by improving hypercalciuria.

Methods

This is a prospective, randomized, cross-over study. Stone-formers and controls were randomized to a control or a high salt diet for 2 days. After washout, the participants received the diet they were not exposed to previously. After each diet, we obtained 24-hour urine and fasting serum studies.

Results

At baseline, there was no significant difference for urinary UMOD secretion between stone-formers and controls. In contrast to our hypothesis, we found that urinary UMOD secretion was significantly reduced after the salt load in controls but not in stone-formers.

Conclusion

There was no lower baseline urine UMOD level in stone-formers. After salt loading, we show lower urinary UMOD secretion in controls but not in stone-formers. As UMOD enhances NKCC2 contributing to hypertension, acute downregulation of UMOD after a salt loading makes physiologically sense.

Salt-loading reduces uUMOD in controls only (P<0.05).

Baseline.